PJT Partners' 15min chart shows Bollinger Bands expanding upward, bullish marubozu signal.

According to Pjt Partners' 15-minute chart, the market trend is currently driven by buyers, as indicated by the Bollinger Bands Expanding Upward and Bullish Marubozu pattern at 08/20/2025 13:30. This suggests that the market is experiencing strong upward momentum, and it is likely that bullish sentiment will continue. As such, buyers are in control of the market, and it is advisable to maintain a bullish outlook.

Title: Market Trends: Bullish Momentum Indicators Point to Continued Upside

According to Pjt Partners' 15-minute chart, the market trend is currently driven by buyers, as indicated by the Bollinger Bands Expanding Upward and Bullish Marubozu pattern at 08/20/2025 13:30. This suggests that the market is experiencing strong upward momentum, and it is likely that bullish sentiment will continue. As such, buyers are in control of the market, and it is advisable to maintain a bullish outlook.

The Bollinger Bands, a technical indicator that measures volatility, have expanded upward, indicating an increase in price volatility. This expansion can signal a potential reversal in the market's price trend. The Bullish Marubozu, a candlestick pattern, is characterized by a long body with no shadows above or below. This pattern suggests that the market is being driven by strong buying pressure [1].

This development follows a broader trend of narrowing Bollinger Bands and KDJ Death Cross formations observed in several other stocks, including ASGN and Cushing NextGen [2, 3]. The KDJ Golden Cross and Bullish Marubozu patterns triggered at 08/20/2025 13:30 suggest a shift in momentum towards the upside, indicating that the stock price has the potential to continue increasing, as buyers are currently in control of the market and bullish momentum is likely to persist [1].

While these technical indicators provide insights into potential market movements, it is crucial for investors to consider these signals in conjunction with fundamental analysis and broader market conditions. As of July 7, 2025, several notable companies have seen updates to their analyst ratings and price targets, reflecting the evolving opinions of financial experts. Positive Outlook: - Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [1]. - Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [1]. - CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [1]. - Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1]. - Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [1]. - Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [1]. - Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [1]. - Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [1]. - JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [1]. - Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [1]. - Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1]. - MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [1]. - Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [1]. - Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [1]. - Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [1]. - Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [1]. - Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [1]. - Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [1]. - Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [1]. - Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [1]. - PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [1]. - Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [1]. Neutral Outlook: - Allegiant Travel (ALGT) was initiated with a Neutral rating by UBS Group, with a price target lowered from $60.00 to $59.00 [1]. - Alaska Air Group (ALK) was initiated with a Neutral rating and a $49.00 target by UBS Group [1]. - AvalonBay (AVB) was rated "Hold" by Evercore ISI with a price target of $229.00 [1]. - Benitec Biopharma (BNTC) was initiated with a "Buy" rating by TD Cowen [1]. - Broadridge Financial Solutions (BR) received a "Hold" rating from D.A. Davidson with a $220.00 target [1]. - Camden Property (CPT) was rated "Hold" by Evercore ISI with a price target of $124.00, implying a 13.26% upside [1]. - Citigroup (C) had a price target of $77.00 set by Evercore ISI, while Oppenheimer reiterated an "Outperform" rating [1]. - Coinbase Global (COIN) received a "Hold" rating from Goldman Sachs with a $268.00 price target [1]. - Coterra Energy (CTRA) was assigned a "Buy" rating by Barclays Capital with a $37.00 target [1]. - Crexendo (CXDO) was rated "Buy" at Northland Securities with a price target of $8.00 [1]. - Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1]. - DoubleVerify (DV) had its "Buy" rating reiterated by Craig Hallum [1]. - Emerson Electric Company (EMR) was rated "Buy" by TD Cowen, with a price target of $150.00 [1]. - Enovix (ENVX) received a "Buy" rating from Northland Securities with a $25.00 target [1]. - Enterprise Products Partners (EPD) was initiated with a "Hold" rating and a $33.00 price target by TD Cowen [1]. - Equity Residential (EQR) was upgraded by Evercore ISI from In-Line to

References:
[1] https://www.ainvest.com/news/benitec-biopharma-kdj-golden-cross-bullish-marubozu-triggered-15-minute-chart-2508-38/
[2] https://www.ainvest.com/news/pjt-partners-15min-chart-shows-bollinger-bands-narrowing-kdj-death-cross-2508-88/
[3] https://www.reuters.com/legal/transactional/rbc-bmo-planning-sale-2-billion-canadian-payments-venture-sources-say-2025-08-14/